Envoy Medical Inc. Expands Global Patent Portfolio with Three New Issuances in Australia

Reuters

01 Jul

<a href="https://laohu8.com/S/COCH">Envoy Medical Inc.</a> Expands Global Patent Portfolio with Three New Issuances in Australia

Envoy Medical Inc. has announced the issuance of three new patents in Australia, further bolstering its intellectual property portfolio. The patents include Australian Patent No. 2021391396, titled "Implantable Cochlear Implant Stimulation Calibration," focusing on cochlear implant systems with a testing circuit for current calibration during stimulation. Another, Australian Patent No. 2021390456, titled "Combination Hearing Aid and Cochlear Implant System," addresses the integration of cochlear implants with external hearing aids to improve simultaneous operation. The third, Australian Patent No. 2022227534, titled "Recharge System for Implantable Battery," involves systems for predicting thermal doses and optimizing charging conditions for implanted rechargeable batteries.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envoy Medical Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 257292) on July 01, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2548006428"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2548006428\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2548006428?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-01 20:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2548006428","market":"nz","top_or_hot":-1,"title":"Envoy Medical Inc. Expands Global Patent Portfolio with Three New Issuances in Australia","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/COCH\">Envoy Medical Inc.</a> Expands Global Patent Portfolio with Three New Issuances in Australia\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/COCHW\">Envoy Medical Inc.</a> has announced the issuance of three new patents in Australia, further bolstering its intellectual property portfolio. The patents include Australian Patent No. 2021391396, titled \"Implantable Cochlear Implant Stimulation Calibration,\" focusing on cochlear implant systems with a testing circuit for current calibration during stimulation. Another, Australian Patent No. 2021390456, titled \"Combination Hearing Aid and Cochlear Implant System,\" addresses the integration of cochlear implants with external hearing aids to improve simultaneous operation. The third, Australian Patent No. 2022227534, titled \"Recharge System for Implantable Battery,\" involves systems for predicting thermal doses and optimizing charging conditions for implanted rechargeable batteries.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envoy Medical Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 257292) on July 01, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Envoy Medical Inc. Expands Global Patent Portfolio with Three New Issuances in Australia</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEnvoy Medical Inc. Expands Global Patent Portfolio with Three New Issuances in Australia\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-07-01 20:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/COCH\">Envoy Medical Inc.</a> Expands Global Patent Portfolio with Three New Issuances in Australia\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/COCHW\">Envoy Medical Inc.</a> has announced the issuance of three new patents in Australia, further bolstering its intellectual property portfolio. The patents include Australian Patent No. 2021391396, titled \"Implantable Cochlear Implant Stimulation Calibration,\" focusing on cochlear implant systems with a testing circuit for current calibration during stimulation. Another, Australian Patent No. 2021390456, titled \"Combination Hearing Aid and Cochlear Implant System,\" addresses the integration of cochlear implants with external hearing aids to improve simultaneous operation. The third, Australian Patent No. 2022227534, titled \"Recharge System for Implantable Battery,\" involves systems for predicting thermal doses and optimizing charging conditions for implanted rechargeable batteries.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envoy Medical Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 257292) on July 01, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250701:nNDL9kd8RN:1","article_id":"2548006428","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2548006428","pubTimestamp":1751371298,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Envoy Medical Inc. has announced the issuance of three new patents in Australia, further bolstering its intellectual property portfolio. The patents include Australian Patent No. 2021391396, titled \"Implantable Cochlear Implant Stimulation Calibration,\" focusing on cochlear implant systems with a testing circuit for current calibration during stimulation. Another, Australian Patent No. 2021390456, titled \"Combination Hearing Aid and Cochlear Implant System,\" addresses the integration of cochlear implants with external hearing aids to improve simultaneous operation. The third, Australian Patent No. 2022227534, titled \"Recharge System for Implantable Battery,\" involves systems for predicting thermal doses and optimizing charging conditions for implanted rechargeable batteries.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","COCH":"Envoy Medical Inc."},"translate_title":"Envoy Medical Inc.在澳大利亚发行了三项新专利，扩大了全球专利组合","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"COCH":0.9},"content_text":"Envoy Medical Inc. Expands Global Patent Portfolio with Three New Issuances in Australia\n    \n\nEnvoy Medical Inc. has announced the issuance of three new patents in Australia, further bolstering its intellectual property portfolio. The patents include Australian Patent No. 2021391396, titled \"Implantable Cochlear Implant Stimulation Calibration,\" focusing on cochlear implant systems with a testing circuit for current calibration during stimulation. Another, Australian Patent No. 2021390456, titled \"Combination Hearing Aid and Cochlear Implant System,\" addresses the integration of cochlear implants with external hearing aids to improve simultaneous operation. The third, Australian Patent No. 2022227534, titled \"Recharge System for Implantable Battery,\" involves systems for predicting thermal doses and optimizing charging conditions for implanted rechargeable batteries.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envoy Medical Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 257292) on July 01, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}